Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects. Issue 4 (2nd January 2022)

Record Type:: Journal Article
Title:: Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects. Issue 4 (2nd January 2022)
Main Title:: Initial combination of metformin, sitagliptin, and empagliflozin in drug‐naïve patients with type 2 diabetes: Safety and metabolic effects
Authors:: Lim, Soo
Sohn, Minji
Shin, Yujin
Ferrannini, Ele
Abstract:
Is Part Of:: Diabetes, obesity & metabolism. Volume 24:Issue 4(2022)
Journal:: Diabetes, obesity & metabolism
Issue:: Volume 24:Issue 4(2022)
Issue Display:: Volume 24, Issue 4 (2022)
Year:: 2022
Volume:: 24
Issue:: 4
Issue Sort Value:: 2022-0024-0004-0000
Page Start:: 757
Page End:: 762
Publication Date:: 2022-01-02
Subjects:: drug mechanism -- SGLT2 inhibitor -- type 2 diabetes
Diabetes -- Periodicals
Obesity -- Periodicals
Metabolism -- Disorders -- Periodicals
Clinical pharmacology -- Periodicals
616.462
Journal URLs:: http://www.blackwellpublishing.com/journal.asp?ref=1462-8902&site=1 ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1463-1326 ↗
http://onlinelibrary.wiley.com/ ↗
DOI:: 10.1111/dom.14627 ↗
Languages:: English
ISSNs:: 1462-8902
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 3579.601970
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21066.xml